收缩
NEWS
NEWS
Your current location:Home > News Center
BIOMEDICA Issued New Product: Soluble Semaphorin 4D ELISA
Update time:2018年05月24日
Biomedica is happy to announce the launch of a highly specific
 
soluble Semaphorin 4D ELISA
 
for the quantitative determination of human biologically active sSEMA4D in clinical samples
Highlights:
 
 GUARANTEED PERFORMANCE - rigorous validation and QC for plasma samples in clinical trials

√ HIGHLY SPECIFIC - characterized antibodies and reagents
 
√ REPRODUCIBLE - specific analysis of soluble non-shed SEMA4D
 
√ RELIABLE - 7 human plasma based standards and 2 controls for biologically reliable data
 
√ LOW SAMPLE VOLUME - only 10 µl / well required
 
√ PROPRIETARY PRODUCT - in-house R&D and production
 
Areas of interest:
 
Osteology •  Oncology •  Immunology •  Neurology
 
Semaphorin 4D is widely studied for its role in neural connectivity, vascularization, cell migration, the immune response, tumor progression, and bone remodeling.
HomeAbout usNews CentreProducts CentreRecruitmentContact us
© Copyright Beijing Rongzhi Haida Biotech Co., Ltd.
Beijing headquarters Tel:+86.10.5889.5809 +86.10.5889.5646 Fax: +86.10.5889.5611 E-mail:market@rz-biotech.com
(BJ)ICP12047214 Technical support:wanmeiweb.com